We are live on ! Find out more
AQR Capital Management

AQR Capital Management Portfolio holdings

AUM $218B
1-Year Est. Return 29.41%
This Fund
S&P 500
This Quarter Est. Return
+1.59%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$36.4B
AUM Growth
-$720M
Cap. Flow
-$2.61B
Cap. Flow %
-7.18%
Top 10 Hldgs %
9.35%
Holding
2,708
New
200
Increased
858
Reduced
1,062
Closed
203

Sector Composition

Rank Sector Weight
1 Healthcare 14.33%
2 Technology 12.68%
3 Energy 9.74%
4 Financials 9.4%
5 Industrials 9.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRO icon
701
Brown & Brown
BRO
$23.9B
$5.93M 0.02%
369,000
+78,000
+27% +$1.23M
KOF icon
702
Coca-Cola Femsa
KOF
$23.2B
$5.93M 0.02%
58,892
+19,800
+51% +$2.17M
ANIK icon
703
Anika Therapeutics
ANIK
$287M
$5.92M 0.02%
161,623
+116,000
+254% +$5.01M
SLXP
704
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
$5.9M 0.02%
37,786
-5,200
-12% -$754K
EBS icon
705
Emergent Biosolutions
EBS
$248M
$5.89M 0.02%
276,636
-101,100
-27% -$2.31M
FMBI
706
DELISTED
First Midwest Bancorp Inc/IL
FMBI
$5.88M 0.02%
365,121
-61,600
-14% -$1.03M
ZG icon
707
Zillow
ZG
$7.63B
$5.84M 0.02%
150,936
+81,531
+117% +$3.69M
PII icon
708
Polaris
PII
$4.07B
$5.83M 0.02%
38,925
-13,369
-26% -$1.93M
ICPT
709
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$5.82M 0.02%
24,600
+16,757
+214% +$4.27M
AYI icon
710
Acuity Brands
AYI
$10.8B
$5.79M 0.02%
49,181
+22,700
+86% +$2.68M
PCRX icon
711
Pacira BioSciences
PCRX
$997M
$5.76M 0.02%
59,401
+44,900
+310% +$4.37M
RGEN icon
712
Repligen
RGEN
$9.25B
$5.72M 0.02%
287,125
-90,200
-24% -$1.9M
SAFM
713
DELISTED
Sanderson Farms Inc
SAFM
$5.71M 0.02%
64,961
+34,600
+114% +$3.27M
PTC icon
714
PTC
PTC
$16B
$5.7M 0.02%
154,325
+3,077
+2% +$118K
RPT.PRD
715
DELISTED
RPT Realty 7.25% Series D Cumulative Convertible Perpetual Preferred Shares of Beneficial Interest
RPT.PRD
$5.64M 0.02%
93,250
CW icon
716
Curtiss-Wright
CW
$25.5B
$5.64M 0.02%
85,582
-4,500
-5% -$303K
TFX icon
717
Teleflex
TFX
$5.98B
$5.64M 0.02%
53,690
+15,500
+41% +$1.66M
AUXL
718
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
$5.63M 0.02%
188,599
+151,799
+412% +$3.22M
CTRE icon
719
CareTrust REIT
CTRE
$9.74B
$5.63M 0.02%
393,510
+142,546
+57% +$2.42M
ITGR icon
720
Integer Holdings
ITGR
$4.26B
$5.62M 0.02%
144,564
-4,388
-3% -$188K
CUBE icon
721
CubeSmart
CUBE
$9.41B
$5.6M 0.02%
311,361
-41,100
-12% -$760K
WBS icon
722
Webster Financial
WBS
$12.8B
$5.59M 0.02%
191,823
-71,680
-27% -$2.13M
DYN
723
DELISTED
Dynegy, Inc.
DYN
$5.59M 0.02%
193,600
+169,500
+703% +$5.03M
SIVB
724
DELISTED
SVB Financial Group
SIVB
$5.57M 0.02%
49,654
-8,400
-14% -$932K
CQB
725
DELISTED
CHIQUITA BRANDS INTL (NEW)
CQB
$5.56M 0.02%
391,556
-32,240
-8% -$395K

Similar funds

AQR Capital Management's Q3 2014 Portfolio in Review

As of Q3 2014, AQR Capital Management held 2,708 positions worth $36.4B, down 1.9% from $37.1B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.

AQR Capital Management withdrew a net $2.61B in Q3 2014, closing 203 positions and reducing 1,062 holdings. Its most notable exit was FOREST LABORATORIES INC, an estimated $243M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Energy.

Against the trend, AQR Capital Management opened a new position in BALLY TECHNOLOGIES, INC. worth $80.5M.

  • AQR Capital Management's largest Q3 2014 buy was BALLY TECHNOLOGIES, INC.: 997,907 shares worth $80.5M.
  • AQR Capital Management added most to Shire pic in Q3 2014, an estimated $147M increase.
  • AQR Capital Management's biggest Q3 2014 reduction was Western Refining Inc, cutting an estimated $148M.
  • AQR Capital Management fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $243M.
  • AQR Capital Management's ten largest holdings make up 9.4% of its $36.4B portfolio in Q3 2014.
  • AQR Capital Management opened 200 new positions and closed 203 in Q3 2014.
  • AQR Capital Management's portfolio value fell 1.9% quarter-over-quarter to $36.4B.

Based on AQR Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.